IIM Nagpur, AIIMS Nagpur open admissions for PG Certificate Prog in advanced health mgmt

IMT News Desk
IMT News Desk
· 2 min read

Admissions to the programme conclude on November 2, 2025, with batches commencing from November 23, 2025

The Indian Institute of Management Nagpur (IIM Nagpur), in collaboration with All India Institute of Medical Sciences Nagpur (AIIMS Nagpur) and TimesPro – a higher edtech platform, announced admissions to the sixth batch of the Post Graduate Certificate Programme in Advanced Healthcare Management. This programme aims to equip healthcare professionals with the necessary skills and knowledge to navigate the complex healthcare ecosystem while shaping future leaders who will drive innovation, efficiency and excellence in their organisations.

The 12-month blended learning programme is the first-ever collaboration between AIIMS Nagpur and IIM Nagpur, combining their healthcare and management expertise. It involves a four-day campus immersion where the AIIMS Nagpur faculty will deliver lectures and masterclasses at IIM Nagpur, providing a holistic learning experience. The programme will cover modules such as healthcare management, policy, finance, operations, technology, analytics, HR and strategy. Learners will gain expertise in managing various healthcare institutions and prepare for diverse industry roles, positioning them for leadership and guiding their organisations into the future.

Dr Bhimaraya Metri Director, IIM Nagpur said, “We are pleased to collaborate with AIIMS Nagpur and TimesPro to announce the sixth batch of the Post Graduate Certificate Programme in Advanced Healthcare Management. The healthcare sector is experiencing exceptional growth and investment, creating a substantial need for highly skilled professionals. This programme will equip our learners with versatile and cross-functional capabilities crucial for this sector.”

Dr Prashant P Joshi, Executive Director, AIIMS Nagpur said, “The Post Graduate Certificate Programme in Advanced Healthcare Management aims to nurture the next generation of healthcare executives with the skills and knowledge required to lead the industry. Our partnership with IIM Nagpur and TimesPro ensures a unique learning experience that bridges the gap between healthcare expertise and effective management strategies.”

Admissions to the programme conclude on November 2, 2025, with batches commencing from November 23, 2025.

Read Next

Centre Reaffirms Commitment to Building Healthcare Infrastructure Across Northeast India; Nadda Inaugurates Super-Specialty Hospital in Meghalaya
News
June 5, 2026

Centre Reaffirms Commitment to Building Healthcare Infrastructure Across Northeast India; Nadda Inaugurates Super-Specialty Hospital in Meghalaya

Union Health Minister J P Nadda on Thursday declared that the Central Government remains firmly committed to strengthening healthcare infrastructure across the Northeast and ensuring that advanced medical services reach people living in remote and underserved areas of the region. Nadda made these remarks while inaugurating ARHI Hospital in Meghalaya’s Ri-Bhoi district- a new super-specialty […]
Article by: IMT News Desk
Hexagon Nutrition Raises Rs 41.66 Crore from Anchor Investors Ahead of Rs 139-Crore IPO Opening Today
News
June 5, 2026

Hexagon Nutrition Raises Rs 41.66 Crore from Anchor Investors Ahead of Rs 139-Crore IPO Opening Today

Mumbai-based Hexagon Nutrition Ltd has mobilised Rs 41.66 crore from anchor investors ahead of its initial public offering (IPO), which opened for public subscription on June 5 and will remain open until June 9, 2026. According to a circular uploaded on BSE’s website, the company allotted a total of 92.57 lakh equity shares to anchor […]
Article by: IMT News Desk
Otsuka’s Voyxact Shows Kidney Function Preservation in Late-Stage IgAN Trial, Setting Stage for Full FDA Approval
News
June 5, 2026

Otsuka’s Voyxact Shows Kidney Function Preservation in Late-Stage IgAN Trial, Setting Stage for Full FDA Approval

Otsuka Pharmaceutical has reported that its approved kidney disease drug Voyxact (sibeprenlimab) preserved kidney function over 12 months in a late-stage clinical study, marking a significant milestone in the treatment of immunoglobulin A nephropathy (IgAN), a serious autoimmune condition that progressively damages the kidneys. In the Phase 3 VISIONARY trial involving 320 participants, patients who […]
Article by: IMT News Desk
Akums Receives European CEP Approval for Cefpodoxime Proxetil
News
June 4, 2026

Akums Receives European CEP Approval for Cefpodoxime Proxetil

Akums Drugs & Pharmaceuticals Ltd. has received a Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & HealthCare (EDQM) for its active pharmaceutical ingredient (API), Cefpodoxime Proxetil. The CEP certification confirms that Akums’ manufacturing process and quality standards for Cefpodoxime Proxetil comply with the requirements of the European Pharmacopoeia. The […]
Article by: IMT News Desk